• 154,759+ Medical Conferences
  • 285 Specialties
  • 11,301 Organizers
  • 156,541 Speakers
  • 159 Countries
  • 4,789 Cities
CME Conference Registrations Sold


Measuring Quality of Life Important With Diabetes Tx

Measuring Quality of Life Important With Diabetes Tx

Wed, Dec 13, 2017

WEDNESDAY, Dec. 13, 2017 (HealthDay News) -- Patients with diabetes report worse quality of life (QoL) with more intensified treatment, according to a study published in online Nov. 28 in Diabetes Care.

Clare Bradley, Ph.D., from the University of London, and colleagues assessed predictors (patient characteristics, physician-reported adherence, complications, and glycosylated hemoglobin) for patient-reported outcome measures (PROMs) among 5,813 patients with type 2 diabetes.

The researchers found that mean PROM scores indicated that QoL was "good." Patient-reported treatment satisfaction exceeded physicians' estimates. Worse QoL was predicted by intensifying treatments to three oral agents or insulin regimens (P < 0.01). Use of insulin alone also predicted worse QoL (P < 0.02), as did hypoglycemia worry (P < 0.007). There were no significant associations between any treatment and EuroQoL-5 Dimension visual analogue scale health status.

"The findings demonstrate the importance of measuring QoL alongside health status and other patient-reported outcomes when evaluating diabetes treatments with a view to protecting QoL and facilitating adherence and long-term glycemic control," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including AstraZeneca and Bristol-Myers Squibb, both of which funded the trial.

Abstract/Full Text (subscription or payment may be required)